Electrophysiological evaluation of brainstem function in patients with idiopathic normal pressure hydrocephalus
Objective: To explore the brainstem function in patients with idiopathic normal pressure hydrocephalus (iNPH) by means of a multimodal electrophysiological assessment of trigeminal, facial, and…Aberrant brain plasticity in patients with Parkinson’s disease and levodopa-induced dyskinesias
Objective: We performed this monocentric cross-sectional study aimed to identify the alterations of cortical plasticity at primary motor cortex (M1) in PD patients with and…Correlates of gait impairment in parkinson’s disease
Objective: Assess gait dysfunction in patients with PD and its correlation with clinical (motor and non-motor symptoms) and radiological findings. Background: Gait impairment is one…In vivo positive amyloid PET in a patient with PDD, always reliable?
Objective: To describe a singular case of an early-onset Parkinson disease (PD) patient with PD dementia who presented in vivo positive 18 F-Flutebetamol PET but…How helpful is the Swallow tail sign in Parkinson’s disease?
Objective: To report a patient diagnosed with idiopathic Parkinson’s disease (PD) with an intact Swallow tail sign (STS) shown in his MR susceptibility-weighted imaging (SWI)…Teleprogramming Reduces the Time Needed to Optimize DBS Therapy: Results from the ROAM-DBS study
Objective: To present early outcomes from the ROAM-DBS (Deep Brain Stimulation) trial on the clinical efficacy of teleprogramming for DBS demonstrating more rapid improvement when…A multimodal approach for diagnosis of early Multiple System Atrophy (MSA)
Objective: To describe the use of neuroimaging and fluid biomarkers to improve the diagnostic accuracy of early MSA. Background: The diagnosis of early MSA is…Long-term evolution of advanced Parkinson’s disease burden: second interim results from the international PROSPECT observational study
Objective: To evaluate the long-term evolution of clinical and economic outcomes and treatment patterns of patients with advanced Parkinson’s disease (PD) who have symptoms that…Kufor-Rakef syndrome, report of two unrelated cases from Chile studied with DAT-PET
Objective: To describe two previously unreported, unrelated cases of atypical parkinsonism caused by mutations in ATP13A2gene. Background: ATP13A2 gene, previously known as PARK 9, has recently…Quantification of Striatal and Extrastriatal Dopamine Transporters with [18F]PR04.MZ and [18F] PI- 2620 PET in Patients with Progressive Supranuclear Palsy.
Objective: We aim to evaluate the differences in striatal subregional dopamine transporter loss between Parkinson disease (PD) and progressive supranuclear palsy (PSP) of any stage…
- « Previous Page
- 1
- …
- 79
- 80
- 81
- 82
- 83
- …
- 186
- Next Page »